The colonisation of Multi-Drug-Resistant Organisms (MDRO) is an increasing problem in the health care system and has a serious impact on the community. This colonisation has to be avoided at all cost to prevent severe problems such as infection, especially prior to surgical interventions, in catheterised patients, or in immunosuppressed patients.
Several clinical studies have shown that cleansing with antimicrobial cleansers (e.g. with Prontoderm®) the night and the morning before the planned operation can reduce the incidence of post-operative surgical site infections (SSI).*
*Source Zywiel MB et al. Int Orthop. 2011 Jul; 35(7):1001–1006.
The percentage of resistant organisms has increased in hospital settings over the past years. Approximately 15% of patients who acquired Methicillin-resistant Staphylococcus aureus (MRSA) developed a subsequent infection. Prontoderm is able to inhibit MDRO growth, spread or transmission. The efficacy for MRSA, ESBL/ESCR and VRE are proven by EN13727. Furthermore Prontoderm shows a leave on antimicrobial barrier effect for up to 24 hours.